LAUREN GRADWELL: Open Payments
NPI 1275010407 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 17 payments from 6 companies in 2025. Trend: 2023 $250 · 2024 $22 · 2025 $640
Food & beverage: $583Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $211 |
| Optinose US, Inc. | 3 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $102 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, Xhance, NUCALA, NEFFY.
Industry payments across PA — which companies pay providers there.
